Kind Pharmaceuticals LLC
Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS6
PHASE 3 / 2-32
RECRUITING4
READOUTS ≤12 MONTHS3
| TRIAL | PHASE | STATUS | CONDITION | N | PRIMARY COMPLETION |
|---|---|---|---|---|---|
| AND017 capsules NCT07494409 |
P3 | Recruiting | Anemia Due to Chronic Kidney Disease | 300 | 2026-10-30 |
| AND017 NCT06304103 |
P2 | Recruiting | Myelodysplastic Syndromes | 63 | 2026-12 |
| AND017 capsules NCT06302491 |
P2 | Recruiting | β -Thalassemia | 64 | 2026-12 (+12 mo) |
| AND017 NCT07487727 |
P3 | Recruiting | Anemia Due to Chronic Kidney Disease | 240 | 2026-12-01 |
| AND017 NCT06075030 |
P2 | Not yet recruiting | Chemotherapy Induced Anemia | 36 | 2027-12 (+36 mo) |
| AND017 NCT06075043 |
P2 | Not yet recruiting | Cancer-Related Anemia | 36 | 2028-05 (+40 mo) |